Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells

Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells

Background/Aims: CD133+CD44+ cancer stem cells previously isolated from laryngeal squamous cell carcinoma (LSCC) cell lines showed strong malignancy and tumorigenicity. However, the molecular mechanism underlying the enhanced malignancy remained unclear. Methods: Cell proliferation assay, spheroid-f...

Full description

Bibliographic Details
Main Authors:	Yongyan Wu, Yuliang Zhang, Min Niu, Yong Shi, Hongliang Liu, Dongli Yang, Fei Li, Yan Lu, Yunfeng Bo, Ruiping Zhang, Zhenyu Li, Hongjie Luo, Jiajia Cui, Jiangwei Sang, Caixia Xiang, Wei Gao, Shuxin Wen
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2018-06-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Laryngeal squamous cell carcinoma CD133+CD44+ Cancer stem cells Whole transcriptome analysis Circular RNA
Online Access:	https://www.karger.com/Article/FullText/490992

Similar Items

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
by: Mohammed Saeed Rozeik, et al.
Published: (2017-07-01)

The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer
by: Peng Jiang, et al.
Published: (2024-04-01)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger M, et al.
Published: (2009-03-01)

Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
by: Xiaomei Gao, et al.
Published: (2018-07-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

Prostate Cancer Stem Cells: The Role of CD133
by: Jianhui Yang, et al.
Published: (2022-11-01)

Low CD8<sup>+</sup> T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44<sup>+</sup>/CD133<sup>+</sup> Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
by: Ya-Chin Hou, et al.
Published: (2019-04-01)

Influence of CD133+ expression on patients' survival and resistance of CD133+ cells to anti-tumor reagents in gastric cancer
by: De-Hu Chen, et al.
Published: (2015-12-01)

The Utilization and Limitation of CD133 Epitopes in Lung Cancer Stem Cells Research
by: Yin CHEN, et al.
Published: (2011-10-01)

Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis
by: Aseel Kamil Mohammed Al-mosawi, et al.
Published: (2020-04-01)

CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
by: Sook-Kyoung Heo, et al.
Published: (2020-04-01)

CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas
by: Bi Y, et al.
Published: (2022-08-01)

Role of CD133 in human embryonic stem cell proliferation and teratoma formation
by: Hua Wang, et al.
Published: (2020-05-01)

Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
by: Abdel-Rahman N. Zekri, et al.
Published: (2017-03-01)

Predictive value of ALDH1 and CD44 positivity for radiotherapy response and prognosis in early-stage glottic laryngeal squamous cell carcinoma
by: Ozgur Surmelioglu, et al.
Published: (2022-06-01)

CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line
by: Motahareh Rajabi Fomeshi, et al.
Published: (2016-04-01)

CD133 does not enrich for the stem cell activity in vivo in adult mouse prostates
by: Xing Wei, et al.
Published: (2016-05-01)

Pretreatment detection of circulating and tissue CD133+ CD44+ cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer
by: Zahran AM, et al.
Published: (2019-02-01)

Quantitative Cell Numbers and Density of Mesangial Volume in a Rat Model with Induced Hyperglycemic and Treated with Mononuclear Derived CD133 Positive Cells
by: Durdi Qujeq, et al.
Published: (2014-05-01)

Characterization of Megakaryocyte Progenitor Cells Differentiated from Umbilical Cord Blood CD133+ and CD133– Cells
by: Alireza Goodarzi, et al.
Published: (2007-01-01)

CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity
by: Andrea Kelemen, et al.
Published: (2022-02-01)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
by: Natalia Izycka, et al.
Published: (2023-01-01)

CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells
by: Angelique Sao-Mai Sy Tay, et al.
Published: (2021-09-01)

Human Umbilical Cord Blood-Derived CD133+CD34+ Cells Protect Retinal Endothelial Cells and Ganglion Cells in X-Irradiated Rats through Angioprotective and Neurotrophic Factors
by: Siyu Chen, et al.
Published: (2022-02-01)

CD133 expression in patients with peripheral neuroblastic tumor: a systematic review
by: Hedieh Nazarzadeh, et al.
Published: (2015-10-01)

CD133 expression in patients with peripheral neuroblastic tumor: a systematic review
by: Hedieh Nazarzadeh, et al.
Published: (2015-09-01)

Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma
by: Farid RM, et al.
Published: (2019-05-01)

Characteristics of Cancer Stem Cells and Their Potential Role in Endometrial Cancer
by: Karolina Frąszczak, et al.
Published: (2024-03-01)

Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133
by: Hideki Izumi, et al.
Published: (2023-03-01)

Effect of Staurosporine on Neural Differentiation of CD133+ Umbilical Cord Blood Cells
by: Faezeh Faghihi, et al.
Published: (2008-01-01)

Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast
by: Nagwa Abd El-Sadek Ahmed, et al.
Published: (2022-02-01)

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
by: Yao-Li Chen, et al.
Published: (2017-07-01)

LONG TERM CLINICAL RESULTS OF AUTOLOGOUS CD133+ BONE MARROW CELLS TRANSPLANTATION IN ST ELEVATION MYOCARDIAL INFARCTION PATIENTS
by: M. A. Kirgizova, et al.
Published: (2016-03-01)

The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133+ renal stem cells
by: Hong Liu, et al.
Published: (2021-06-01)

The role of CD133 in cancer: a concise review
by: Paige M. Glumac, et al.
Published: (2018-07-01)

Imperatorin Targets MCL-1 to Sensitize CD133+ Lung Cancer Cells to γδ-T Cell-Mediated Cytotoxicity
by: Changxuan You, et al.
Published: (2018-08-01)

CD133, Selectively Targeting the Root of Cancer
by: Jörg U. Schmohl, et al.
Published: (2016-05-01)

Tropism of mesenchymal stem cell toward CD133+ stem cell of glioblastoma in vitro and promote tumor proliferation in vivo
by: Lorena Favaro Pavon, et al.
Published: (2018-11-01)

PHYSIOLOGICAL ROLE OF BONE MARROW ADULT STEM CELL CD133+
by: J. IRGASHEVA, et al.
Published: (2017-04-01)

CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients
by: Abdullah Ozkok, et al.
Published: (2017-07-01)